Rigel(RIGL) - 2024 Q3 - Earnings Call Transcript

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Ray Furey - Executive Vice President, General Counsel & Corporate Secretary. Raul Rodriguez - President & Chief Executive Officer Dave Santos - Chief Commercial Officer Lisa Rojkjaer - Chief Medical Officer Dean Schorno - Chief Financial Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Kalpit Patel - B. Riley Securities Farzin Haque - Jefferies Operator Greetings an ...